Max Healthcare – “Range-Bound but Resilient: Can Bulls Break Out?”

(₹1,181) continues to trade inside a broad consolidation zone, but the long-term structure remains bullish. The price is holding above the 9-EMA, signalling strong short-term momentum. RSI near 55–60 suggests neither overbought nor oversold, giving room for further upside. Pivot levels indicate key resistance at R1 ₹1339 and major support at ₹1150–1100 levels. Fundamentals: India’s leading hospital chain with strong market share in Delhi NCR. Revenue and EBITDA have grown steadily YoY, supported by higher occupancy and better case mix. Margin expansion continues due to premiumisation of services. Low debt + healthy cash flows make it a stable long-term compounder. Analyst View: Sentiment remains positive across brokerages. Consensus: BUY with upside potential as structural demand for healthcare grows.